Palatin Technologies Inc SEC filings PTN
Palatin Technologies Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 12, 2003. Its latest annual report, Form 10-K, was filed on Sep 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Aug 3, 2026 (shareholder vote results). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jun 25, 2026 | Jun 25, 2026 |
| DEF 14A | Proxy statement | Jun 30, 2025 | Jun 18, 2025 |
| PRE 14A | Preliminary proxy statement | Jun 18, 2025 | Jun 18, 2025 |
| DEF 14A | Proxy statement | May 28, 2024 | May 25, 2024 |
| DEF 14A | Proxy statement | May 19, 2023 | Jun 20, 2023 |
| DEF 14A | Proxy statement | May 24, 2022 | Jun 24, 2022 |
| PRE 14A | Preliminary proxy statement | May 13, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | Jun 21, 2021 | — |
| DEF 14A | Proxy statement | Apr 26, 2021 | Jun 8, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2021 | Jun 8, 2021 |
| DEFA14A | Additional proxy material | Jun 29, 2020 | — |
| DEFA14A | Additional proxy material | May 11, 2020 | — |
| DEF 14A | Proxy statement | May 11, 2020 | Jun 25, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 30, 2020 | Jun 25, 2020 |
| DEFA14A | Additional proxy material | May 10, 2019 | — |
| DEF 14A | Proxy statement | May 10, 2019 | Jun 20, 2019 |
| DEFA14A | Additional proxy material | May 17, 2018 | — |
| DEF 14A | Proxy statement | May 17, 2018 | Jun 26, 2018 |
| DEFA14A | Additional proxy material | Apr 28, 2017 | — |
| DEF 14A | Proxy statement | Apr 28, 2017 | Jun 8, 2017 |
| DEFA14A | Additional proxy material | Apr 22, 2016 | — |
| DEF 14A | Proxy statement | Apr 22, 2016 | Jun 9, 2016 |
| DEFA14A | Additional proxy material | Apr 24, 2015 | — |
| DEF 14A | Proxy statement | Apr 24, 2015 | Jun 11, 2015 |
| DEFA14A | Additional proxy material | May 6, 2014 | — |
| DEF 14A | Proxy statement | May 6, 2014 | Jun 19, 2014 |
| DEF 14A | Proxy statement | May 15, 2013 | Jun 27, 2013 |
| PRE 14A | Preliminary proxy statement | Apr 29, 2013 | Jun 27, 2013 |
| DEF 14A | Proxy statement | Jul 31, 2012 | Sep 27, 2012 |
| PRE 14A | Preliminary proxy statement | Jul 20, 2012 | Sep 27, 2012 |
| DEFA14A | Additional proxy material | Apr 20, 2012 | — |
| DEF 14A | Proxy statement | Apr 20, 2012 | Apr 20, 2012 |
| DEF 14A | Proxy statement | Apr 5, 2011 | Apr 5, 2011 |
| PRE 14A | Preliminary proxy statement | Mar 17, 2011 | Mar 17, 2011 |
| DEF 14A | Proxy statement | Apr 7, 2010 | Apr 6, 2010 |
| PRE 14A | Preliminary proxy statement | Mar 22, 2010 | Mar 22, 2010 |
| DEF 14A | Proxy statement | Mar 31, 2009 | Mar 30, 2009 |
| PRE 14A | Preliminary proxy statement | Mar 16, 2009 | Mar 16, 2009 |
| DEF 14A | Proxy statement | Oct 29, 2007 | Oct 26, 2007 |
| DEF 14A | Proxy statement | Oct 30, 2006 | Oct 30, 2006 |
| DEF 14A | Proxy statement | Oct 28, 2005 | Oct 28, 2005 |
| DEF 14A | Proxy statement | May 4, 2005 | May 4, 2005 |
| DEF 14A | Proxy statement | Oct 28, 2004 | Oct 28, 2004 |
| DEF 14A | Proxy statement | Jul 29, 2004 | Jul 29, 2004 |
| PREM14A | Special meeting | Jul 13, 2004 | Jul 13, 2004 |
| DEF 14A | Proxy statement | Nov 14, 2003 | Nov 14, 2003 |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTN (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NJ
- Headquarters
- Cranbury, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 911216
- Former names
- INTERFILM INC (until Jun 14, 1996)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.